Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD2014 - Potent mTOR Inhibitor for Cancer Research | APExBIO
AZD2014 induces similar on-/off-target and cytostatic effects in R/R ...
AZD2014 induced cell cycle arrest at G0/G1 phase in CRPC cells. C4‐2 ...
The effects of AZD2014 on migration and invasion in CRPC cells. C4‐2 ...
Activity of AZD2014 in a number of in vivo models. A to E, in vivo ...
AZD2014 activated autophagy in CRPC cells. C4‐2, CWR22RV1, C4‐2 DOCR ...
The biochemical activity of AZD2014 in blocking mTORC1/C2 signalling in ...
Fluorescence characterisation of AZD2014. A) UV-VIS spectrum of AZD2014 ...
AZD2014 and dasatinib therapy in combination reduces the metabolic ...
AZD2014 is more effective than rapamycin or FRAX597 in decreasing cell ...
AZD2014 attenuate eIF4E phosphorylation in TSC2+/− mice. aTsc2+/− mice ...
Ibrutinib and AZD2014 synergistically induce apoptosis. (A) Cells were ...
Effect of AZD2014 and rapamycin on EMT in cystic/papillary lesions of ...
AZD2014 inhibited proliferation and induces apoptosis in CPRC cells ...
AZD2014 and rapamycin inhibited cell proliferation, colony formation ...
Effect of AZD2014 and rapamycin on EMT in solid tumors of Tsc2 +/− ...
Effect of AZD2014 and rapamycin on mTORC1 and mTORC2 in renal tumors of ...
Synergistic interaction between AZD1208 and AZD2014 in AML cells. A ...
Benefits of AZD8055 and AZD2014 over rapamycin to inhibit PI3K/Akt/mTOR ...
AZD2014 inhibited cell proliferation in OSCC cell lines. SCC4 and SCC25 ...
The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM ...
Induction of cell cycle arrest and apoptosis by the KPT-185 and AZD2014 ...
Effect of AZD2014 and radiation on SCC4 and SCC25 colony formation. (A ...
Combination treatment with AZD2014 and IR causes G1 and G2 phase cell ...
Pretreatment with everolimus or AZD2014 sensitizes the cells to ...
Analysis of gene-expression changes by different AZD2014 schedules and ...
Potent antitumour of the mTORC1/2 dual inhibitor AZD2014 in docetaxel ...
In vivo effect of irinotecan (Irino) and AZD2014 combination on tumor ...
A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients ...
Combined AZD2014 and dasatinib treatment significantly inhibits tumor ...
AZD2014 Radiosensitizes Oral Squamous Cell Carcinoma by Inhibiting AKT ...
(PDF) The mTORC1/mTORC2 Inhibitor AZD2014 Enhances the Radiosensitivity ...
Live cell uptake and imaging of AZD2014. Confocal imaging of AZD2014 (7 ...
AZD8186 and AZD2014 exhibit synergistic effects in vivo a–c DLBCL cell ...
Combination of irinotecan and AZD2014 prevents the phosphorylation of ...
Autophagy induction by AZD2014 or TMX prevented DOX-induced cell death ...
PDT of AZD2014 in adherent monolayer cells. A) Compilation of confocal ...
Comparison of AZD2014 (100 nM) and Rapamycin (100 nM) on phenylephrine ...
AZD2014 (Vistusertib) | mTORC1/2 inhibitor | Buy from Supplier AdooQ®
AZD8186 and AZD2014 synergistically impair the growth of DLBCL cells in ...
Effect of combination treatment with AZD2014 and IR or IR alone on ...
PRY-Dual mTORC1:2 Inhibitor AZD2014 Diminishes Myeloid-Derived ...
Effects of AZD2014 on phenylephrine (PE)-induced cardiac hypertrophy. a ...
Figure 4 from The novel combination of dual mTOR inhibitor AZD2014 and ...
Two dimensional docking pattern and molecular interactions of AZD2014 ...
Vistusertib (AZD2014) | 购买mTOR 抑制剂 - Selleck
Vistusertib (AZD2014) | mTORC Inhibitor | MedChemExpress
Analysis of AZD2014-RT combination. (A) Dose-response curves for SF7761 ...
MTOR KI mouse model is useful for precisely assessing on-/off-target ...
(PDF) AZD2014, an inhibitor of mTORC1 and mTORC2, is highly effective ...
美国APExBIO中文官网 - AZD2014|Novel mTOR inhibitor|CAS# 1009298-59-2
AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro ...
In vivo response to targeted therapies and chemotherapy in LAR PDX. (A ...
Vistusertib (AZD2014) | mTOR 阻害剤
Analysis of AZD2014-chemotherapy combination. (A) Dose-response curves ...
Inhibition of mTOR pathway decreased the level of glycolytic metabolism ...
(PDF) Evaluation of the combination of the dual m-TORC1/2 inhibitor ...
Oncology Reports
First-in-human pharmacokinetic and pharmacodynamic study of the dual m ...
HR is defective in everolimus-or AZD2014-pretreated cells: Clone A and ...
Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade ...
Vistusertib (AZD2014) | mTOR inhibitor | Probechem Biochemicals
Structure, biochemical, and cellular activity of AZD2014. A, chemical ...
Figure 6 from AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly ...
Time course of changes in myocardial mTOR signaling in phenylephrine ...
Dramatic antitumor effects of the dual mTORC1 and mTORC2 inhibitor ...
Figure 2 from AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly ...
Figure 4 from AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly ...
Vistusertib (AZD2014) | CAS 1009298-59-2 | AbMole BioScience ...
Synergism between irinotecan (Irino) and AZD8055, and between ...
Frontiers | m7G-related genes predict prognosis and affect the immune ...
(PDF) Vistusertib and Paclitaxel in Ovarian Cancer
